LUKASZ SZARPAK to Antidepressive Agents
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Antidepressive Agents.
Connection Strength
0.201
-
Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov. Psychiatry Res. 2025 Aug; 350:116559.
Score: 0.201